Browse the corpus

H2 receptor blockers, or histamine-2 receptor antagonists (H2RAs), are gastric acid-suppressing agents frequently used to treat various gastric conditions. The U.S. Food and Drug Administration has approved the short-term administration of H2RAs for patients with uncomplicated gastroesophageal reflux disease (GERD), gastric or duodenal ulcers, gastric hypersecretion, and mild to infrequent heartburn or indigestion. H2RAs may also be used off-label for stress ulcer prophylaxis, esophagitis, gastritis, gastrointestinal bleeding, or urticaria. H2RAs are sometimes part of a multidrug regimen for Helicobacter pylori eradication. In the United States, 3 H2RAs are FDA-approved and available either over-the-counter (OTC) or by prescription: famotidine, cimetidine, and nizatidine. Depending on the dose, famotidine and cimetidine may require a prescription. Higher doses of nizatidine require a prescription. A solid clinical understanding of H2RAs is crucial for effectively managing gastrointestinal disorders. This activity describes the pharmacological features of H2 blockers and emphasizes the interprofessional team's role in promoting their safety, equipping healthcare professionals with essential knowledge, and enhancing patient outcomes and care standards. Objectives: Evaluate the mechanism of action of H2 receptor blockers. Assess the adverse drug reactions associated with H2 receptor blocker administration. Identify the indications for H2 receptor blocker therapy. Implement effective collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from H2 receptor blockers. Access free multiple choice questions on this topic.

Signs and Symptoms of Overdose H2 receptor antagonists have a broad therapeutic index; severe toxicity is rare. Toxic H2RA levels may cause inhibition of H2 receptors in the myocardium and central nervous system. Central nervous system depression, hypotension, and bradycardia are rare but have been observed after rapid intravenous H2RA infusion. Management of Overdose Treatment for H2RA overdose typically involves discontinuation of the drug and supportive care measures and may include decontamination with gastric lavage or activated charcoal.

Many H2 blockers are available over the counter. While these drugs are relatively safe, they may produce severe adverse effects when combined with other CNS drugs. Patient education by the interprofessional healthcare team is critical to preventing toxicity and improving outcomes for patients receiving H2 receptor-blocking therapy. Pharmacists should check for drug interactions and inquire of patients in the retail setting if they encounter a patient purchasing H2 receptor antagonists as an over-the-counter option. Patients should be advised not to combine these agents with other CNS drugs or alcohol and refrain from taking them for prolonged periods.[32] An interprofessional team approach and communication among clinicians (MD, DO, NP, PA), pharmacists, and nurses are crucial to decreasing potential adverse effects and improving patient outcomes related to H2 blockers.